These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3678278)

  • 41. Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.
    Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
    Br J Nutr; 2015 Apr; 113(7):1096-101. PubMed ID: 25762411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased PIVKA-II concentrations in patients with cystic fibrosis.
    de Montalembert M; Lenoir G; Saint-Raymond A; Rey J; Lefrère JJ
    J Clin Pathol; 1992 Feb; 45(2):180-1. PubMed ID: 1541707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Phospholipid-glycerides, cross-resistance of erythrocytes, malonic dialdehyde level and alpha-tocopherol levels in the plasma and erythrocytes of rats with alloxan diabetes before and after combined antioxidant therapy].
    Karagezian KG; Gevorkian DM
    Vopr Med Khim; 1989; 35(5):27-30. PubMed ID: 2617931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidative damage in red blood cells of vitamin E deficient patients.
    Mazor D; Brill G; Shorer Z; Moses S; Meyerstein N
    Clin Chim Acta; 1997 Sep; 265(1):131-7. PubMed ID: 9352136
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
    Rust P; Eichler I; Renner S; Elmadfa I
    Int J Vitam Nutr Res; 1998; 68(2):83-7. PubMed ID: 9565821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.
    Lepage G; Champagne J; Ronco N; Lamarre A; Osberg I; Sokol RJ; Roy CC
    Am J Clin Nutr; 1996 Jul; 64(1):87-93. PubMed ID: 8669420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns.
    Sokol RJ; Reardon MC; Accurso FJ; Stall C; Narkewicz M; Abman SH; Hammond KB
    Am J Clin Nutr; 1989 Nov; 50(5):1064-71. PubMed ID: 2816791
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of vitamin E on plasma malondialdehyde-like material in man.
    Cordova C; Musca A; Violi F; Alessandri C; Ghiselli A; Iuliano L; Balsano F
    Thromb Haemost; 1984 Jul; 51(3):347-8. PubMed ID: 6495254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversible tremor in an infant with vitamin E deficiency and cystic fibrosis.
    Lo Barco T; Ghobert AL; Lucca F; Galati G; Proietti J; Cantalupo G
    Lancet; 2021 Jul; 398(10295):156. PubMed ID: 34246348
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis.
    Hakim F; Kerem E; Rivlin J; Bentur L; Stankiewicz H; Bdolach-Abram T; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):347-53. PubMed ID: 17873748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of vitamin E deficiency on neurologic function in patients with cystic fibrosis.
    Cynamon HA; Milov DE; Valenstein E; Wagner M
    J Pediatr; 1988 Oct; 113(4):637-40. PubMed ID: 3171788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
    Dorlöchter L; Aksnes L; Fluge G
    Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children.
    Jain SK; McVie R; Smith T
    Diabetes Care; 2000 Sep; 23(9):1389-94. PubMed ID: 10977039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin A, provitamin A and vitamin E serum concentrations in cystic fibrosis patients.
    Bui MH
    Int J Vitam Nutr Res; 1988; 58(3):354-5. PubMed ID: 3198325
    [No Abstract]   [Full Text] [Related]  

  • 55. Fatty acid abnormalities in cystic fibrosis.
    Farrell PM; Mischler EH; Engle MJ; Brown DJ; Lau SM
    Pediatr Res; 1985 Jan; 19(1):104-9. PubMed ID: 3918287
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D in infants with cystic fibrosis diagnosed by newborn screening.
    Neville LA; Ranganathan SC
    J Paediatr Child Health; 2009; 45(1-2):36-41. PubMed ID: 19208064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative anemia and iron deficiency in cystic fibrosis.
    Ater JL; Herbst JJ; Landaw SA; O'Brien RT
    Pediatrics; 1983 May; 71(5):810-4. PubMed ID: 6835767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Peroxidation of erythrocyte lipids and levels of vitamin E in red blood cells in children with chronic renal insufficiency].
    Martino F; Lubrano R; Ruberto U; Mannarino O; Galletti E; D'Eufemia P; Giardini O
    Minerva Pediatr; 1989 Jun; 41(6):315-7. PubMed ID: 2601649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of vitamin E therapy on plasma and erythrocyte lipid peroxidation in chronic hemodialysis patients.
    Yalçin AS; Yurtkuran M; Dilek K; Kilinç A; Taga Y; Emerk K
    Clin Chim Acta; 1989 Oct; 185(1):109-12. PubMed ID: 2620447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Importance of the analysis of lipid peroxides in children with pneumonia].
    Ananenko AA; Spektor EB; Utkina EA; Politova LN; Riabinskaia TF
    Pediatriia; 1978 Apr; (4):31-4. PubMed ID: 652454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.